TOG
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Obstetrician & Gynaecologist 2006;8:2:103-106
doi: 10.1576/toag.8.2.103.27229
Copyright © 2006 by the Royal College of Obstetricians and Gynaecologists.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baxter, A. J
Right arrow Search for Related Content
PubMed
Right arrow Articles by Baxter, A. J

New developments

Advances in hysteroscopic sterilisation

Andrew J Baxter, MRCOG, Consultant Obstetrician and Gynaecologist

The Jessop Wing, The Royal Hallamshire Hospital, Sheffield, S10 2SF, UK E-mail: ted.baxter{at}sth.nhs.uk

Hysteroscopic sterilisation performed in the outpatient setting avoids the risks and discomfort associated with the laparoscopic procedure. A variety of techniques has been assessed and discarded, mainly because of poor efficacy. More recently, the Essure® procedure has been shown to be easy to perform, acceptable to women and highly effective at five-year follow-up. However, concerns remain about the absolute irreversibility of this method of sterilisation. Other devices in development may prove to be equally effective but reversible. When introducing any new therapy it is important to ensure that informed consent is taken and outcomes are prospectively audited.

Keywords Essure® / hysteroscopy / outpatient procedures / sterilisation







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Royal College of Obstetricians and Gynaecologists.